PEGOZAFERMIN REDUCED PROGRESSION TO CIRRHOSIS: A POST-HOC ANALYSIS FROM THE PHASE 2B ENLIVEN STUDY

被引：0
|
作者：
Hartsfield, Cynthia [1 ]
Schattenberg, Jorn [2 ]
Sanyal, Arun [3 ]
Abdelmalek, Manal [4 ]
Margalit, Maya [1 ]
Gottwald, Mildred [1 ]
Feng, Shibao [1 ]
Agollah, Germaine [1 ]
Tseng, Leo [1 ]
Mansbach, Hank [1 ]
Loomba, Rohit [5 ]
机构：
[1] 89bio, San Francisco, CA USA
[2] UKS, Oswego, NY USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
[4] Mayo Clin Rochester, Rochester, MN USA
[5] Univ Calif San Diego, San Diego, CA USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
622
引用
收藏
页码：S456 / S457
页数：2
相关论文
共 50 条
  • [1] Impact of atacicept on hematuria in IGA nephropathy: post-hoc analysis of the phase 2b ORIGIN study
    Floege, Juergen
    Barratt, Jonathan
    Maes, Bart
    Cooper, Kerry
    Lin, Celia
    Wei, Xuelian
    Barbour, Sean
    Phoon, Richard
    Kim, Sung Gyun
    Tesar, Vladimir
    Jha, Vivekanand
    Wadhwani, Shikha
    Lafayette, Richard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [2] Impact of atacicept on hematuria in IGA nephropathy: post-hoc analysis of the phase 2b ORIGIN study
    Floege, Juergen
    Barratt, Jonathan
    Maes, Bart
    Cooper, Kerry
    Lin, Celia
    Wei, Xuelian
    Barbour, Sean
    Phoon, Richard
    Kim, Sung Gyun
    Tesar, Vladimir
    Jha, Vivekanand
    Wadhwani, Shikha
    Lafayette, Richard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I710 - I711
  • [3] QUANTITATIVE ANALYSIS AND INTEGRATION OF MACHINE LEARNING FOR BIOMARKER ASSESSMENTS AND THEIR ASSOCIATION WITH TREATMENT RESPONSE: INSIGHTS FROM THE ENLIVEN PHASE 2B TRIAL OF PEGOZAFERMIN
    Mansbach, Oliver
    Sanyal, Arun
    Savic, Rada
    Tseng, Leo
    Balic, Kemal
    Feng, Shibao
    Tsai, Lillian
    Gottwald, Mildred
    Margalit, Maya
    Agollah, Germaine
    Mansbach, Hank
    Anstee, Quentin
    HEPATOLOGY, 2024, 80 : S559 - S560
  • [4] Week 48 results from the phase 2b ENLIVEN extension study investigating pegozafermin for the treatment of metabolic dysfunction-associated steatohepatitis with fibrosis
    Loomba, Rohit
    Abdelmalek, Manal F.
    Kowdley, Kris V.
    Alkhouri, Naim
    Harrison, Stephen A.
    Schattenberg, Joern M.
    Gottwald, Mildred D.
    Feng, Shibao
    Agollah, Germaine D.
    Hartsfield, Cynthia L.
    Mansbach, Hank
    Margalit, Maya
    Sanyal, Arun J.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S72 - S72
  • [5] RAPIDITY OF ULCERATIVE COLITIS SYMPTOM IMPROVEMENTS DURING FILGOTINIB INDUCTION: PHASE 2B/3 SELECTION STUDY POST-HOC ANALYSIS
    Morison, Ben
    Danese, Silvio
    Hibi, Toshifumi
    Ritter, Timothy E.
    Dinoso, Jason B.
    Hsieh, Jeremy
    Yun, Chohee
    Zhang, Jie
    Zhao, Sally
    Loftus, Edward V.
    Rogler, Gerhard
    GUT, 2021, 70 : A93 - A93
  • [6] Effect of Baseline MTX Dose on Clinical Efficacy and Safety in Rheumatoid Arthritis Patients Treated with Filgotinib: Post-Hoc Analysis from a Phase 2B Study
    Westhovens, Rene
    van der Aa, Annegret
    Jamoul, Corinne
    Tasset, Chantal
    Harrison, Pille
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [7] HIGHER PAIN VARIATION DURING THE SCREENING PHASE IS ASSOCIATED WITH A LARGER PLACEBO RESPONSE - POST-HOC ANALYSIS OF A PHASE 2B KNEE OSTEOARTHRITIS TRIAL
    Bentin, Jakob M.
    Miller, Claire Prener
    Mondragon, Alejandro Castillo
    Adrian, Ida Sofie
    Arendt-Nielsen, Lars
    Alexandersen, Peter
    Bihlet, Asger R.
    OSTEOARTHRITIS AND CARTILAGE, 2024, 32 : S37 - S38
  • [8] EASI-75 interpretation from a patient perspective - a phase 2b post-hoc analysis of dupilumab in adults with moderate-to-severe atopic dermatitis
    Poulin, Y.
    Tyring, S.
    Kimura, T.
    Andria, M.
    Ghorayeb, E.
    Eckert, L.
    Chao, J.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 70 - 70
  • [9] Unbiased analysis of knee cartilage thickness change over three years after sprifermin vs. placebo treatment - A post-hoc analysis from the phase 2B FORWARD study
    Eckstein, Felix
    Maschek, Susanne
    Wirth, Wolfgang
    Ladel, Christoph
    Bihlet, Asger Reinstrup
    Knight, Chris
    Somberg, Kenneth
    Zhao, Luping
    OSTEOARTHRITIS AND CARTILAGE OPEN, 2024, 6 (04):
  • [10] Effects of Tezepelumab on Asthma Exacerbations and Type 2 Biomarkers in Patients with Severe, Uncontrolled Asthma with and Without Nasal Polyps: Results from a Post-Hoc Analysis of the Phase 2b PATHWAY Study
    Emson, C.
    Corren, J.
    Saapa, K.
    Hellqvist, A.
    Parnes, J. R.
    Colice, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345